Similar articles

• Panic attack precipitated by fluoxetine.

  Saran A, Halaris A. Saran A, et al. J Neuropsychiatry Clin Neurosci. 1989 Spring;1(2):219-20. doi: 10.1176/jnp.1.2.219. J Neuropsychiatry Clin Neurosci. 1989. PMID: 2521065 No abstract available.
• Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.

  Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD. Michelson D, et al. Am J Psychiatry. 1998 Nov;155(11):1570-7. doi: 10.1176/ajp.155.11.1570. Am J Psychiatry. 1998. PMID: 9812120 Clinical Trial.
• Evidence of a suffocation alarm system sensitive to clinically-effective treatments with the panicolytics clonazepam and fluoxetine.

  Schimitel FG, Müller CJ, Tufik S, Schenberg LC. Schimitel FG, et al. J Psychopharmacol. 2014 Dec;28(12):1184-8. doi: 10.1177/0269881114552714. Epub 2014 Oct 2. J Psychopharmacol. 2014. PMID: 25277323
• Immunomodulatory effects of fluoxetine: A new potential pharmacological action for a classic antidepressant drug?

  Di Rosso ME, Palumbo ML, Genaro AM. Di Rosso ME, et al. Pharmacol Res. 2016 Jul;109:101-7. doi: 10.1016/j.phrs.2015.11.021. Epub 2015 Nov 28. Pharmacol Res. 2016. PMID: 26644208 Review.
• Review article: tegaserod for chronic constipation.

  Johanson JF. Johanson JF. Aliment Pharmacol Ther. 2004 Nov;20 Suppl 7:20-4. doi: 10.1111/j.1365-2036.2004.02187.x. Aliment Pharmacol Ther. 2004. PMID: 15521851 Review.